Wave Life Sciences (WVE) News
NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
WVE news summary
We found 14 recent headlines mentioning Wave Life Sciences (WVE): 1 in the past week and 9 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. WVE is making an outsized move today, down 5.88% at $2.56, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Wave Life Sciences Ltd. Stockholders Approve 11,000,000 Share Increase for Equity Incentive Plan", was published by Nasdaq on Nov 19, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Wave Life Sciences headlines
- Wave Life Sciences Ltd. Stockholders Approve 11,000,000 Share Increase for Equity Incentive PlanWave Life Sciences Ltd. held its Annual Meeting of Stockholders on November 12, 2026. Out of 197,228,058 shares of common stock issued and outstanding and eligible to vote as of the record date of…Nasdaq
- Wave Life Sciences Highlights WVE-007 (INHBE siRNA) Progress at ObesityWeek® 2026INLIGHT Phase 1 data continue to support WVE-007’s novel mechanism of action to improve body composition by inducing fat loss without muscle loss, and support a once- or twice-yearly dosing regimenGlobeNewswire
- Wave Life Sciences to Present at Jefferies Global Healthcare Conference in LondonCAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to…GlobeNewswire
- Wave: 3 Key Takeaways for Long-Term InvestorsKey PointsWave aligned with the FDA on a single trial for WVE-006.Nasdaq
- Wave Life Sciences (WVE) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Wave Life Sciences Ltd. Reports Third Quarter 2026 Financial ResultsWave Life Sciences Ltd. reported its financial results for the third quarter ended September 30, 2026, and provided updates on its clinical pipeline. The company reported cash, cash equivalents, and…Nasdaq
- Wave Life Sciences GAAP EPS of -$0.30 beats by $0.03, revenue of $13.16M beats by $8.77MSeeking Alpha
- Wave Life Sciences Reports Third Quarter 2026 Financial Results and Provides Business UpdatePlanning underway for registrational trial of WVE-006 (RNA editing) in AATD, with an interim analysis for potential accelerated approval based on AATD biomarkersGlobeNewswire
- Wave Life Sciences Q3 2026 Earnings PreviewSeeking Alpha
- Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out forGlaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.NasdaqGSK, WVE
- Wave Life Sciences Third Quarter 2026 Financial Results Scheduled for October 27, 2026CAMBRIDGE, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to…GlobeNewswire
- Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026CAMBRIDGE, Mass., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to…GlobeNewswire
- Wave Life Sciences to Present at Chardan’s 10th Annual Healthcare ConferenceCAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to…GlobeNewswire
- Biggest Stock Movers Today, Dec. 8: CFLT, UL, & MoreKey PointsMajor stock market indexes were mixed on Thursday.NasdaqUL, IBM, APD, WVE